D.E. Shaw & Co’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$37.4M Buy
153,000
+107,300
+235% +$25M 0.02% 803
2025
Q4
$9.46M Buy
45,700
+15,700
+52% +$3.1M 0.01% 1810
2025
Q3
$5.56M Sell
30,000
-10,000
-25% -$1.71M ﹤0.01% 2117
2025
Q2
$6.11M Sell
40,000
-13,000
-25% -$2M ﹤0.01% 1872
2025
Q1
$8.79M Sell
53,000
-111,800
-68% -$17.5M 0.01% 1493
2024
Q4
$23.8M Buy
164,800
+34,000
+26% +$5.27M 0.02% 932
2024
Q3
$21.2M Sell
130,800
-33,100
-20% -$5.27M 0.02% 964
2024
Q2
$24M Sell
163,900
-121,300
-43% -$18M 0.02% 792
2024
Q1
$45.1M Sell
285,200
-61,200
-18% -$9.74M 0.04% 529
2023
Q4
$54.3M Buy
346,400
+17,600
+5% +$2.7M 0.05% 449
2023
Q3
$51.2M Buy
328,800
+88,000
+37% +$14.5M 0.05% 420
2023
Q2
$39.9M Buy
240,800
+142,200
+144% +$23M 0.04% 524
2023
Q1
$15.3M Sell
98,600
-111,400
-53% -$18M 0.02% 1065
2022
Q4
$37.1M Sell
210,000
-29,300
-12% -$5.06M 0.04% 562
2022
Q3
$39.1M Sell
239,300
-38,500
-14% -$6.51M 0.05% 493
2022
Q2
$49.3M Buy
277,800
+39,800
+17% +$7.09M 0.06% 402
2022
Q1
$42.2M Sell
238,000
-105,100
-31% -$17.9M 0.04% 569
2021
Q4
$58.7M Buy
343,100
+68,900
+25% +$11.3M 0.05% 479
2021
Q3
$44.3M Sell
274,200
-71,600
-21% -$12.2M 0.04% 586
2021
Q2
$57M Buy
345,800
+174,700
+102% +$28.9M 0.05% 471
2021
Q1
$28.1M Buy
171,100
+46,900
+38% +$7.59M 0.03% 745
2020
Q4
$19.5M Sell
124,200
-20,900
-14% -$3.08M 0.02% 969
2020
Q3
$21.6M Sell
145,100
-155,300
-52% -$23M 0.02% 787
2020
Q2
$42.2M Buy
300,400
+100,400
+50% +$14.6M 0.05% 422
2020
Q1
$26.2M Buy
200,000
+185,000
+1,233% +$26.2M 0.04% 491
2019
Q4
$2.19M Sell
15,000
-20,000
-57% -$2.71M ﹤0.01% 2389
2019
Q3
$4.53M Buy
+35,000
New +$4.61M 0.01% 1720
2019
Q1
Sell
-94,000
Closed -$12.1M 3751
2018
Q4
$12.1M Sell
94,000
-160,300
-63% -$22.4M 0.02% 967
2018
Q3
$35.1M Buy
254,300
+46,600
+22% +$6.19M 0.04% 526
2018
Q2
$25.2M Sell
207,700
-262,300
-56% -$32.7M 0.03% 609
2018
Q1
$60.2M Sell
470,000
-98,300
-17% -$13.3M 0.08% 295
2017
Q4
$79.4M Sell
568,300
-70,500
-11% -$9.82M 0.11% 225
2017
Q3
$83M Buy
638,800
+289,800
+83% +$38.4M 0.13% 190
2017
Q2
$46.2M Buy
349,000
+123,400
+55% +$15.7M 0.08% 307
2017
Q1
$28.1M Buy
225,600
+40,600
+22% +$4.85M 0.05% 449
2016
Q4
$21.3M Sell
185,000
-275,100
-60% -$31.8M 0.04% 599
2016
Q3
$54.4M Buy
460,100
+222,500
+94% +$27M 0.1% 253
2016
Q2
$28.8M Buy
237,600
+232,600
+4,652% +$26.4M 0.05% 425
2016
Q1
$541K Sell
5,000
-141,300
-97% -$14.6M ﹤0.01% 2746
2015
Q4
$15M Sell
146,300
-304,000
-68% -$30.6M 0.02% 772
2015
Q3
$42M Sell
450,300
-210,600
-32% -$20.4M 0.06% 359
2015
Q2
$64.4M Buy
660,900
+11,800
+2% +$1.18M 0.1% 248
2015
Q1
$65.3M Sell
649,100
-2,986,500
-82% -$304M 0.1% 231
2014
Q4
$380M Buy
3,635,600
+283,500
+8% +$29.9M 0.49% 22
2014
Q3
$357M Buy
3,352,100
+267,900
+9% +$27.8M 0.46% 28
2014
Q2
$323M Buy
3,084,200
+485,000
+19% +$49M 0.44% 29
2014
Q1
$255M Sell
2,599,200
-477,500
-16% -$44.3M 0.36% 43
2013
Q4
$282M Buy
3,076,700
+507,500
+20% +$46.8M 0.38% 32
2013
Q3
$223M Buy
2,569,200
+634,800
+33% +$56.9M 0.36% 36
2013
Q2
$166M Buy
+1,934,400
New +$164M 0.31% 47

Other funds holding JNJ

D.E. Shaw & Co's JNJ Position: Q1 2026 in Review

D.E. Shaw & Co reduced its Johnson & Johnson (JNJ) stake by 13% in Q1 2026, selling an estimated $27.7M and leaving 764,504 shares worth $187M. The position accounts for 0.11% of the portfolio, ranked #209.

D.E. Shaw & Co first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. The position peaked at $965M in Q3 2019. 4,615 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • D.E. Shaw & Co held 764,504 shares of Johnson & Johnson worth $187M as of Q1 2026.
  • D.E. Shaw & Co sold 118,999 Johnson & Johnson shares in Q1 2026, an estimated $27.7M.
  • Johnson & Johnson made up 0.11% of D.E. Shaw & Co's portfolio in Q1 2026, its #209 holding.
  • D.E. Shaw & Co first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • D.E. Shaw & Co's Johnson & Johnson position peaked at $965M in Q3 2019.
  • 4,615 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.